Mail

UK Markets close in 58 mins

FTSE 100
7,389.98
+87.24(+1.19%)
FTSE 250
19,835.95
+146.93(+0.75%)
AIM
956.64
+9.47(+1.00%)
GBP/EUR
1.1822
+0.0040(+0.34%)
GBP/USD
1.2495
+0.0020(+0.1587%)
BTC-GBP
23,803.73
+624.05(+2.69%)

How to survive and thrive during a cost of living crisis

Top tips on managing the cost everyday life from groceries to holidays

Applied DNA Sciences, Inc. (APDN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.2700

-0.1200

(-8.63%)

As of 04:00PM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	N/A
Enterprise value	N/A
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	N/A
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	0.99
52-week change ³	N/A
S&P500 52-week change ³	N/A
52-week high ³	8.1000
52-week low ³	1.0800
50-day moving average ³	1.7894
200-day moving average ³	3.9599

Share statistics

Avg vol (3-month) ³	66.59k
Avg vol (10-day) ³	36.55k
Shares outstanding ⁵	7.49M
Implied shares outstanding ⁶	N/A
Float ⁸	7.35M
% held by insiders ¹	2.37%
% held by institutions ¹	7.42%
Shares short (28 Apr 2022) ⁴	285.97k
Short ratio (28 Apr 2022) ⁴	6.66
Short % of float (28 Apr 2022) ⁴	3.55%
Short % of shares outstanding (28 Apr 2022) ⁴	3.47%
Shares short (prior month 30 Mar 2022) ⁴	269.36k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	N/A
Trailing annual dividend yield ³	N/A
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	31 Oct 2019
Ex-dividend date ⁴	N/A
Last split factor ²	1:40
Last split date ³	31 Oct 2019

Financial highlights

Fiscal year

Fiscal year ends	29 Sept 2021
Most-recent quarter (mrq)	30 Dec 2021

Profitability

Profit margin	-122.64%
Operating margin (ttm)	-120.51%

Management effectiveness

Return on assets (ttm)	-82.73%
Return on equity (ttm)	-201.10%

Income statement

Revenue (ttm)	11.58M
Revenue per share (ttm)	1.56
Quarterly revenue growth (yoy)	157.80%
Gross profit (ttm)	4.93M
EBITDA	-12.88M
Net income avi to common (ttm)	-14.2M
Diluted EPS (ttm)	-2.0700
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	2.75M
Total cash per share (mrq)	0.37
Total debt (mrq)	N/A
Total debt/equity (mrq)	N/A
Current ratio (mrq)	2.85
Book value per share (mrq)	1.49

Cash flow statement

Operating cash flow (ttm)	-12.93M
Levered free cash flow (ttm)	-9.91M